INTRODUCTION
============

In general, aortic surgery using total circulatory arrest (TCA) requires myocardial protection using hypothermia and cardioplegic solution (CPS), causing decrease of oxygen demand and metabolism in myocardial cell-like routine open heart surgery. At this point, if omission or minimal infusion of CPS is achieved, several potential side effects may be prevented: systemic embolization or aortic rupture by clamping on the diseased ascending aorta, insult of coronary os during direct ostial CPS infusion, myocardial edema and hemodilution by fluid overloading, long time operation and anesthesia-induced complications by prolongation of bypass time and ultrafiltration. The aims of this study are the clinical outcomes and safety of aortic surgery without initial infusion of cardioplegic solution at the moment of TCA and minimal infusion of only retrograde CPS during rewarming.

MATERIALS AND METHODS
=====================

1) Patient demographics
-----------------------

We retrospectively reviewed the medical records and laboratory data of 72 patients who underwent aortic surgery using TCA without initial CPS infusion from January 2006 to June 2009. There were 44 male patients and 28 females. The mean age was 59 years (range, 34 to 84 years). The diagnoses were 44 acute aortic dissections, 22 aortic aneurysms, and 6 cases of intramural hematoma ([Table 1](#T1){ref-type="table"}). There were 4 mortality cases.

2) Surgical techniques
----------------------

After general endotracheal anesthesia, TCA was applied by cooling the body temperature using cardiopulmonary bypass (CPB), and the topical method was achieved using arterial cannulation via the ascending aorta or right axillary artery and venous cannulation via the superior and inferior vena cava under median sternotomy. We did not apply aortic cross clamping or initial CPS infusion at the moment of TCA antegradely by direct ostial infusion after aortotomy or retrogradely via the coronary sinus in the cases that were expected to require circulatory arrest times of about 30 minutes due to procedures such as ascending aorta, hemiarch, and total arch replacement. In the case of aortic valve surgery or valve sparing root replacement, we infused only retrograde 4℃ blood CPS intermittently during rewarming of the body temperature using restart of CPB after distal anastomosis. CPB was weaned and ultrafiltration was applied routinely after the main procedure. We performed isolated replacement of the ascending aorta in 9 cases, ascending aorta and arch replacement in 50 cases, the Bentall operation in 7 cases, aortic valve sparing root replacement (the David procedure) in 5 cases, ascending aorta replacement with aortic valve replacement in 3 cases, and descending aorta replacement with elephant trunk insertion in 5 cases. In addition, the concomitant procedures were femorofemoral artery bypass, right gastroepiploic artery bypass, and coronary artery bypass grafting in 1 case each. There were 43 cases that underwent emergent operations ([Table 1](#T1){ref-type="table"}). The institutional review board approved this study and waived the requirement to obtain the individual patient\'s consent.

RESULTS
=======

The mean TCA time and the lowest nasopharyngeal temperature was 45 minutes (range, 14 to 110 minutes) and 16.4℃ (range, 12.2℃ to 20℃), respectively. The mean CPB time and aortic cross clamping time was 162 minutes (range, 81 to 331 minutes) and 100 minutes (range, 34 to 219 minutes), respectively. A total CPS of 1,050 mL (range, 0 to 3,900 mL) was infused on average. In 15 cases, CPS was not infused. The total amount of free water removed by ultrafiltration was 2,600 mL (range, 800 to 6,000 mL), and the postoperative weight loss was 0.3 kg (range, 4.7 kg loss to 5.7 kg gain) on average.

The assessment of inotropic support was evaluated using the \'inotrope score,\' a variable calculated as (dopamine or dobutamine dose×hour×1)+(epinephrine or norepinephrine dose×hour×100)+(milrinone dose×hour×10), wherein the dose of each inotropic agent were expressed as mcg/kg/min. The average score was 113 points (range, 6.25 to 5,048.5 points), corresponding to the dopamine infusion of 5 mcg/kg/min for 1 day, and the score exceeded 240 points in 16 patients. We administered inotropic agents for an average of 26 hours (range, 1.5 to 482 hours) and under 6 hours postoperatively in 28 patients.

The average creatine kinase MB fraction peak level was 12.75 ng/mL, and 7 cases showed a higher level at above 50 ng/mL. There were postoperative ischemic changes of the electrocardiogram (ECG) in 5 cases. A total of 10 cases of arrhythmia presented with atrial fibrillation (7 patients), sinus arrhythmia (2 patients), and right bundle branch block (1 patients). There was no casethat required a mechanical circulatory assist device. The postoperative intensive care unit stay and hospital stay were 40 hours (range, 15 to 482 hours) and 11 days on average, respectively ([Table 2](#T2){ref-type="table"}). There was no cardiogenic mortality, but there were 4 non-cardiogenic mortality cases including ischemic necrosis of the bowels due to embolism, hypoxic brain damage, sepsis, and a sudden death suspected of aortic rupture.

DISCUSSION
==========

In the basic concept, there exists a safe period during circulatory arrest in open heart and aortic surgery when the cellular function and integrity are intact during the early and late postoperative phase. The safety of the procedure is limited by organ temperature during the safe period in relationship to hypothermia \[[@B1]\]. Since Bigelow et al. \[[@B2]\] reported on the usefulness of hypothermia in cardiac surgery in 1950 \[[@B3]\], Boerema et al. \[[@B4]\] demonstrated that experimental animals had recovered without any remarkable abnormalities after circulatory arrest for the maximum of 15 minutes after cooling using cooling coils via a femoral arteriovenous shunt. In 1960, Guiot et al. \[[@B5]\] and Weiss et al. \[[@B6]\] were the first to report successful applications of hypothermia and circulatory arrest to a human. Contemporary partial bypass, hypothermia, and circulatory arrest were introduced by Lillehei et al. \[[@B7]\] in 1969, and Griepp et al. \[[@B8]\] applied them to arch aneurysm surgery in 1975.

In addition, inducing ischemic myocardial arrest using deep hypothermia at the lowest temperature has been achieved at 22℃ for 45 to 60 minutes as a safe period without myocardial dysfunction, clinically \[[@B9]\]. The biochemical reaction, essential to cellular metabolism, depends on the body temperature \[[@B10]\]. Hypothermia supports the recovery of normal cell structure and function in the reperfusion phase using declination of metabolism during the ischemic period induced by circulatory arrest. At this point, metabolism is directly related to oxygen consumption; therefore, minimization of oxygen consumption and temperature is closely associated with a safe period during arrest \[[@B11]-[@B13]\].

Furthermore, hypothermia reduces the release of excitotoxic amino acids (aspartate and glutamate) \[[@B14]\], calcium influx, and promotes recovery of protein synthesis \[[@B15]\]. It has also been reported as decreasing membrane-bound protein kinase C activity \[[@B16]\] and extending the onset time of ischemic depolarization \[[@B17]\].

Because it is clear that hypothermia reduces oxygen consumption, the application of hypothermia for myocardial protection is now performed universally. The protective effects of hypothermia changes according to the temperature coefficient, the Q~10~ effect, describing the metabolic rate of tissue altered by temperature; theoretically, for every myocardial temperature fall of 10 degrees, the myocardial oxygen consumption (MVO~2~) should reduce by half.

In 1982, Rosenfeldt \[[@B18]\] reported moderate hypothermia, down to 25℃, could reduce over 50% of the MVO~2~, but there was no additional benefit to lowering temperature to 22℃. In 1980, Swanson et al. \[[@B19]\] demonstrated the safety of maintaining deep hypothermia at 4℃, and English et al. \[[@B20]\] presented a rationale for hypothermic myocardial preservation in heart transplantation.

Regional vascular occlusion can be induced by hypothermia and then can result in the \'no reflow phenomenon.\' Ultimately, Blocking of microcirculation inhibits tissue reperfusion followed by tissue damage despite resumption of circulation. However, Norwood et al. \[[@B21]\] proved by experimentation that this phenomenon is not caused by only circulatory arrest itself but by the combined circumstance of severe hypoxia and that low hypothermia to 20℃ even protects it. Hypoxia induces endothelial damage, followed by this phenomenon due to activate release of endothelin-1, the most powerful vasoconstrictor, brings a vicious cycle of insults on the cell. In this hypoxic status, hypothermia was proved to prevent endothelial damage \[[@B22]\].

If both hypothermic circulatory arrest and CPS were applied simultaneously, the merits of each could offset the other. First, because declination of MVO~2~ is not remarkable during the initial phase of circulatory arrest regardless of CPS, the hyperkalemic CPS effect is subtle and second; continued CPB could rewarm or inappropriately reperfuse the myocardium. For these reason, application of only hypothermia without CPS has merit. However, Fremes et al. \[[@B23]\], Weisel et al. \[[@B24]\], and Yau et al. \[[@B25]\] have suggested several faults of hypothermia such as 1) delayed myocardial recovery due to a decrease of fluidity and transmembrane transport of the plasma membrane, ionic imbalance due to an increase of intracellular edema and Na accumulation, and cellular injuries such as protein denaturation, 2) postoperative bleeding tendency, and 3) a long operation time affected by a prolonged bypass time.

Therefore, we believe that hypothermia can be complemented by CPS infusion, but the previously described counterbalance must be considered. Clamping of the diseased ascending aorta or ostial injury induced by the direct coronary ostial CPS infusion catheter after aortotomy may be replaced with retrograde infusion via the coronary sinus; edema and hemodilution that develops from fluid overloading may be controlled by ultrafiltration.

We reviewed postoperative cardiac enzyme and ECG changes to assess the adequacy of myocardial protection. However, the parameters used were not sufficient, and mild myocardial damage may be controlled by postoperative inotropic administration. Therefore, in this study, we quantified the cardiovascular function using the inotrope score as a parameter to distinguish between the damaged and protected myocardium after TCA. The inotrope score was originally introduced by Wernovsky et al. \[[@B26]\] as a quantitative measurement of cardiovascular support. Gaies et al. \[[@B27]\] suggested that the inotrope score can be used as an independent predictor of short-term outcomes of illness severity, morbidity, and mortality in patients suffering from low cardiac output syndrome after open heart surgery.

On a side note, this trial is not a first of all. From a historical perspective, the timing of CPS infusion has changed from just before TCA to just after TCA, and even after distal anastomosis during aortic surgery. Although the timing might be changed according to surgeon\'s preference or for the purpose of procedural ease, it is our opinion that myocardial protection cannot be absolutely guaranteed based on the timing of CPS infusion. Furthermore, prompt restoration of myocardial perfusion after short TCA may permit infusion of delayed CPS or even omission.

In conclusion, we suggest that only hypothermia can protect the myocardium, avoiding complications induced by CPS infusion in aortic surgery using TCA without initial CPS, according to our clinical cases retrospectively reviewed showing favorable outcomes of the intraoperative and postoperative period.

As a matter of course, a simple proximal anastomosis performed by a skilled surgeon or a more advanced operative technique using an artificial graft or substitute can be accomplished without myocardial damage during the short rewarming period due to the aftereffects of hypothermia alone and without inessential CPS infusion. However, there are some limitations of single hypothermia for myocardial or organic protection without CPS infusion; therefore, further evaluation of more complex procedures, such as the aortic root remodeling combined with aortic surgery described above, will be required. In addition, further study will be required to explore myocardial evaluation using other diagnostic tools such as echocardiography, single photon emission computerized tomography, and cardiac magnetic resonance imaging.

While the faults associated with conventional CPS infusion may be considered a limitation of our study, if a \"golden time\" for deep hypothermia alone without the need for the negative effects of myocardial function can be identified by scientific and clinical research, it may become routine to not insert a catheter for CPS infusion. We suggest that if some procedure could be omitted, it would be more effective and scientifically sound.

CONCLUSION
==========

Minimal infusion of only retrograde CPS during rewarming without initial infusion in aortic surgery using TCA is feasible and can be used as a safe surgical modality with acceptable results on the additional basis of large scale clinical studies.
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TCA, total circulatory arrest; CPB, cardiopulmonary bypass time; ACC, aoprtic cross clamping time; CPS, cardioplegic solution; CK-MB, creatine kinase MB; ECG, electrocardiogram; ICU, intensive care unit.

^a)^A variable calculated by (dopamine or dobutamine dose×hr×1)+(epinephrine or norepinephrine dose×hr×100)+(milrinone dose×hr×10), wherein the dose of each inotropic agent is expressed as mcg/kg/min.
